Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era
Roger A Barker, Malin Parmar, Lorenz Studer, Jun Takahashi, Roger A Barker, Malin Parmar, Lorenz Studer, Jun Takahashi
Abstract
Stem cell-based therapies for Parkinson's disease are moving into a new and exciting era, with several groups pursuing clinical trials with pluripotent stem cell (PSC)-derived dopamine neurons. As many groups have ongoing or completed GMP-level cell manufacturing, we highlight key clinical translation considerations from our recent fourth GForce-PD meeting.
Copyright © 2017 Elsevier Inc. All rights reserved.
Source: PubMed